-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$54.5034.01% Upside
Mirum Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. has been rated by research analysts at Robert W. Baird, Evercore ISI, Morgan Stanley, H.C. Wainwright, Cantor Fitzgerald, Stifel Nicolaus in the past 90 days.